Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125308611 | 12530861 | 1 | I | 20151028 | 20160706 | 20160706 | EXP | CA-PFIZER INC-2015369502 | PFIZER | 58.00 | YR | F | Y | 0.00000 | 20160706 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125308611 | 12530861 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 20 MG, WEEKLY | N | 11719 | 20 | MG | /wk | ||||||
| 125308611 | 12530861 | 2 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 20 MG, UNK | N | 0 | 20 | MG | ||||||||
| 125308611 | 12530861 | 3 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | UNK | N | 0 | |||||||||
| 125308611 | 12530861 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | N | 0 | |||||||||||
| 125308611 | 12530861 | 5 | C | PERINDOPRIL | PERINDOPRIL | 1 | 4 MG, DAILY | 0 | 4 | MG | |||||||||
| 125308611 | 12530861 | 6 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | |||||||
| 125308611 | 12530861 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 500 MG, 2X/DAY | 0 | 500 | MG | BID | ||||||||
| 125308611 | 12530861 | 8 | C | METOPROLOL. | METOPROLOL | 1 | 75 MG, 2X/DAY | 0 | 75 | MG | BID | ||||||||
| 125308611 | 12530861 | 9 | C | PANTOLOC /01263204/ | PANTOPRAZOLE SODIUM | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | QD | ||||||||
| 125308611 | 12530861 | 10 | C | FOLIC ACID. | FOLIC ACID | 1 | 5 MG, WEEKLY | 0 | 5 | MG | /wk | ||||||||
| 125308611 | 12530861 | 11 | C | FERROUS FUMARATE | FERROUS FUMARATE | 1 | 300 MG, DAILY | 0 | 300 | MG | |||||||||
| 125308611 | 12530861 | 12 | C | ASA | ASPIRIN | 1 | 81 MG, 1X/DAY | 0 | 81 | MG | QD | ||||||||
| 125308611 | 12530861 | 13 | C | TRAVOPROST | TRAVOPROST | 1 | UNK | 0 | EYE DROPS | ||||||||||
| 125308611 | 12530861 | 14 | C | DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | 1 | UNK | 0 | |||||||||||
| 125308611 | 12530861 | 15 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125308611 | 12530861 | 1 | Rheumatoid arthritis |
| 125308611 | 12530861 | 2 | Rheumatoid arthritis |
| 125308611 | 12530861 | 3 | Rheumatoid arthritis |
| 125308611 | 12530861 | 4 | Pain |
| 125308611 | 12530861 | 14 | Rheumatoid arthritis |
| 125308611 | 12530861 | 15 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125308611 | 12530861 | OT |
| 125308611 | 12530861 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125308611 | 12530861 | Condition aggravated | |
| 125308611 | 12530861 | Decreased appetite | |
| 125308611 | 12530861 | Drug ineffective | |
| 125308611 | 12530861 | Haemoglobin decreased | |
| 125308611 | 12530861 | Hypoglycaemia | |
| 125308611 | 12530861 | Nasal disorder | |
| 125308611 | 12530861 | Oral disorder | |
| 125308611 | 12530861 | Rheumatoid arthritis | |
| 125308611 | 12530861 | Sweating fever | |
| 125308611 | 12530861 | Synovitis | |
| 125308611 | 12530861 | Ulcer | |
| 125308611 | 12530861 | Weight fluctuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125308611 | 12530861 | 1 | 201304 | 201601 | 0 | |
| 125308611 | 12530861 | 2 | 201408 | 201410 | 0 | |
| 125308611 | 12530861 | 3 | 201510 | 0 | ||
| 125308611 | 12530861 | 15 | 20141212 | 0 |